Abingdon, UK Feb 8, 2012 — Penlon Limited is pleased to announce the introduction of the Oriel 4000 Patient Monitor, the flagship model at the head of an all-new range of high specification, new generation patient monitors, providing reliability, usability, outstanding value for money, and network capability for all clinical areas.
For theatre applications the monitor provides state-of-the-art monitoring with full gas analysis and automatic agent identification.
For critical monitoring requirements between theatre, recovery/step-down, and ICU the unique EMS portable multi-parameter transport unit allows continuous patient monitoring and seamless data transfer before and after transport to and from the OR. The EMS has a 3.5-inch display and can monitor up to six vital signs parameters.
Oriel 4000 has a touchscreen option, and also features a configurable display that allows the user to define the parameters to be viewed, and then further customisation through scalable screen elements.
Network connectivity will be provided by a new Central Monitoring Station, to offer our customers an economic solution for centralised viewing and high-capacity patient data storage, and is compatible with our patient well-being index software, Visensia.
Full service support is provided by Penlon’s well established Service Division.
Tag: penlon
Penlon's Oriel 4000 Patient Monitor Launched
Abingdon, UK Feb 8, 2012 — Penlon Limited is pleased to announce the introduction of the Oriel 4000 Patient Monitor, the flagship model at the head of an all-new range of high specification, new generation patient monitors, providing reliability, usability, outstanding value for money, and network capability for all clinical areas.
For theatre applications the monitor provides state-of-the-art monitoring with full gas analysis and automatic agent identification.
For critical monitoring requirements between theatre, recovery/step-down, and ICU the unique EMS portable multi-parameter transport unit allows continuous patient monitoring and seamless data transfer before and after transport to and from the OR. The EMS has a 3.5-inch display and can monitor up to six vital signs parameters.
Oriel 4000 has a touchscreen option, and also features a configurable display that allows the user to define the parameters to be viewed, and then further customisation through scalable screen elements.
Network connectivity will be provided by a new Central Monitoring Station, to offer our customers an economic solution for centralised viewing and high-capacity patient data storage, and is compatible with our patient well-being index software, Visensia.
Full service support is provided by Penlon’s well established Service Division.
Penlon wins a prestigious Queen’s Award… for a fourth time
Abingdon, UK Apr 21, 2010 — The Queen’s Award for Enterprise is the UK’s most prestigious award for business performance and denotes outstanding achievement by UK companies and has been bestowed on Penlon under the ‘International Trade’ category, for its continued record growth and commercial success in overseas markets. This represents the combined business of Anaesthesia Solutions, Medical Gas Pipeline Systems, Laryngoscopes, Oxygen Therapy and Suction.
This is Penlon’s fourth Queen’s Award and truly distinguishes Penlon in this sector. Previous awards were in 1968 and 1976 for Export Achievement, followed in 2002 with a Queen’s Award for Innovation for the highly acclaimed Sigma Delta Vaporizer.
Peter Leyland, CEO commented, ‘Penlon is immensely proud to receive this accolade which reflects the combined expertise and effort of everyone who has contributed to the sustained success of the business and their genuine passion in helping to raise standards of healthcare’.
Penlon wins a prestigious Queen's Award… for a fourth time
Abingdon, UK Apr 21, 2010 — The Queen’s Award for Enterprise is the UK’s most prestigious award for business performance and denotes outstanding achievement by UK companies and has been bestowed on Penlon under the ‘International Trade’ category, for its continued record growth and commercial success in overseas markets. This represents the combined business of Anaesthesia Solutions, Medical Gas Pipeline Systems, Laryngoscopes, Oxygen Therapy and Suction.
This is Penlon’s fourth Queen’s Award and truly distinguishes Penlon in this sector. Previous awards were in 1968 and 1976 for Export Achievement, followed in 2002 with a Queen’s Award for Innovation for the highly acclaimed Sigma Delta Vaporizer.
Peter Leyland, CEO commented, ‘Penlon is immensely proud to receive this accolade which reflects the combined expertise and effort of everyone who has contributed to the sustained success of the business and their genuine passion in helping to raise standards of healthcare’.